PLX
Price
$2.70
Change
+$0.02 (+0.75%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
216.74M
45 days until earnings call
Intraday BUY SELL Signals
XCUR
Price
$1.16
Change
+$0.04 (+3.57%)
Updated
Oct 2 closing price
Capitalization
8.08M
Intraday BUY SELL Signals
Interact to see
Advertisement

PLX vs XCUR

PLX vs XCUR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PLX vs. XCUR commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLX is a Hold and XCUR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PLX vs XCUR: Fundamental Ratings
PLX
XCUR
OUTLOOK RATING
1..100
9086
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
51
Fair valued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
3299
PRICE GROWTH RATING
1..100
3991
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XCUR's Valuation (51) in the null industry is in the same range as PLX (65) in the Servicestothe Health Industry industry. This means that XCUR’s stock grew similarly to PLX’s over the last 12 months.

PLX's Profit vs Risk Rating (69) in the Servicestothe Health Industry industry is in the same range as XCUR (100) in the null industry. This means that PLX’s stock grew similarly to XCUR’s over the last 12 months.

PLX's SMR Rating (32) in the Servicestothe Health Industry industry is significantly better than the same rating for XCUR (99) in the null industry. This means that PLX’s stock grew significantly faster than XCUR’s over the last 12 months.

PLX's Price Growth Rating (39) in the Servicestothe Health Industry industry is somewhat better than the same rating for XCUR (91) in the null industry. This means that PLX’s stock grew somewhat faster than XCUR’s over the last 12 months.

PLX's P/E Growth Rating (91) in the Servicestothe Health Industry industry is in the same range as XCUR (100) in the null industry. This means that PLX’s stock grew similarly to XCUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLXXCUR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (PLX: $2.71 vs. XCUR: $1.16)
Brand notoriety: PLX and XCUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLX: 121% vs. XCUR: 12%
Market capitalization -- PLX: $216.74M vs. XCUR: $8.08M
PLX [@Biotechnology] is valued at $216.74M. XCUR’s [@Biotechnology] market capitalization is $8.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLX’s FA Score shows that 1 FA rating(s) are green while XCUR’s FA Score has 0 green FA rating(s).

  • PLX’s FA Score: 1 green, 4 red.
  • XCUR’s FA Score: 0 green, 5 red.
According to our system of comparison, PLX is a better buy in the long-term than XCUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLX’s TA Score shows that 3 TA indicator(s) are bullish while XCUR’s TA Score has 3 bullish TA indicator(s).

  • PLX’s TA Score: 3 bullish, 5 bearish.
  • XCUR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, XCUR is a better buy in the short-term than PLX.

Price Growth

PLX (@Biotechnology) experienced а -0.37% price change this week, while XCUR (@Biotechnology) price change was -4.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

PLX is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PLX
Daily Signal:
Gain/Loss:
XCUR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSMV20.000.10
+0.52%
Invesco BulletShares 2031 Municipal Bond ETF (BSMV)
MYMJ24.000.09
+0.37%
State Street My2030 Municipal Bond ETF (MYMJ)
DFEM39.730.01
+0.03%
Dimensional Emerging Markets Core Equity 2 ETF (DFEM)
CAOS90.51-0.04
-0.04%
Alpha Architect Tail Risk ETF (CAOS)
ETHD24.15-0.86
-3.44%
ProShares UltraShort Ether ETF (ETHD)

XCUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XCUR has been loosely correlated with XFOR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XCUR jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XCUR
1D Price
Change %
XCUR100%
-2.61%
XFOR - XCUR
34%
Loosely correlated
-2.41%
HRTX - XCUR
26%
Poorly correlated
+13.52%
NNVC - XCUR
25%
Poorly correlated
-3.08%
PLX - XCUR
25%
Poorly correlated
-2.90%
KRYS - XCUR
24%
Poorly correlated
-2.18%
More